Literature DB >> 7648032

A TH1-TH2-like switch in candidiasis: new perspectives for therapy.

P Puccetti1, L Romani, F Bistoni.   

Abstract

An imbalance in TH1-type and TH2-type responses may allow Candida albicans to modify the host response to favor its own persistence. This hypothesis has important consequences for allergy, autoimmunity and co-infection, and also highlights a potential role for cytokine and anti-cytokine therapy in Candida-related pathology.

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7648032     DOI： 10.1016/s0966-842x(00)88931-3

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN： 0966-842X            Impact factor:   17.079


  21 in total

1.  Cytokine gene polymorphisms and the outcome of invasive candidiasis: a prospective cohort study.

Authors:  Melissa D Johnson; Theo S Plantinga; Esther van de Vosse; Digna R Velez Edwards; P Brian Smith; Barbara D Alexander; John C Yang; Dennis Kremer; Gregory M Laird; Marije Oosting; Leo A B Joosten; Jos W M van der Meer; Jaap T van Dissel; Thomas J Walsh; John R Perfect; Bart-Jan Kullberg; William K Scott; Mihai G Netea
Journal:  Clin Infect Dis       Date:  2011-12-05       Impact factor: 9.079

2.  Invasive candidiasis stimulates hepatocyte and monocyte production of active transforming growth factor beta.

Authors:  J J Letterio; T Lehrnbecher; G Pollack; T J Walsh; S J Chanock
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

3.  Comparison of pathogenesis and host immune responses to Candida glabrata and Candida albicans in systemically infected immunocompetent mice.

Authors:  J Brieland; D Essig; C Jackson; D Frank; D Loebenberg; F Menzel; B Arnold; B DiDomenico; R Hare
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

4.  Biochemical and immunological characterization of MP65, a major mannoprotein antigen of the opportunistic human pathogen Candida albicans.

Authors:  M J Gomez; B Maras; A Barca; R La Valle; D Barra; A Cassone
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

5.  Candida pneumonia in the ICU: myth or reality?

Authors:  Jean-Damien Ricard; Damien Roux
Journal:  Intensive Care Med       Date:  2009-06-27       Impact factor: 17.440

Review 6.  Oral candidiasis, HIV, and saliva glucocorticoids.

Authors:  C O Enwonwu; V I Meeks
Journal:  Am J Pathol       Date:  1996-04       Impact factor: 4.307

7.  CD4+ T-helper-cell responses in mice with low-level Candida albicans infection.

Authors:  A Mencacci; R Spaccapelo; G Del Sero; K H Enssle; A Cassone; F Bistoni; L Romani
Journal:  Infect Immun       Date:  1996-12       Impact factor: 3.441

8.  NK cells mediate increase of phagocytic activity but not of proinflammatory cytokine (interleukin-6 [IL-6], tumor necrosis factor alpha, and IL-12) production elicited in splenic macrophages by tilorone treatment of mice during acute systemic candidiasis.

Authors:  José Juan Gaforio; Elena Ortega; Ignacio Algarra; María José Serrano; Gerardo Alvarez de Cienfuegos
Journal:  Clin Diagn Lab Immunol       Date:  2002-11

Review 9.  Macrophages in resistance to candidiasis.

Authors:  A Vázquez-Torres; E Balish
Journal:  Microbiol Mol Biol Rev       Date:  1997-06       Impact factor: 11.056

10.  Measurement of T-cell-derived antigen binding molecules and immunoglobulin G specific to Candida albicans mannan in sera of patients with recurrent vulvovaginal candidiasis.

Authors:  C H Little; G M Georgiou; A Marceglia; H Ogedgebe; R E Cone; D Mazza
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.